PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
- Conditions
- Peripheral Arterial DiseaseCritical Limb IschemiaChronic Limb-Threatening Ischemia
- Interventions
- Device: LimFlow Stent Graft System
- First Posted Date
- 2022-04-06
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- LimFlow, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT05313165
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center, Dallas, Texas, United States
๐บ๐ธUniversity Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
๐บ๐ธUniversity of California, San Diego Health, La Jolla, California, United States
Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study
- Conditions
- Critical Limb IschemiaPeripheral Artery Disease
- First Posted Date
- 2020-03-11
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- LimFlow, Inc.
- Target Recruit Count
- 192
- Registration Number
- NCT04304105
- Locations
- ๐บ๐ธ
LA Foot & Ankle Clinic - St. Vincent's Hospital, Los Angeles, California, United States
๐บ๐ธHarbor- UCLA Medical Center, Torrance, California, United States
๐บ๐ธDenver Veterans Affairs Medical Center, Denver, Colorado, United States
PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
- Conditions
- Peripheral Artery DiseaseChronic Limb-Threatening IschemiaCritical Lower Limb IschemiaArterial OcclusionCritical Limb IschemiaArterial DiseasePeripheral Artery OcclusionPeripheral Vascular DiseaseVascular DiseasesPeripheral Arterial Disease
- Interventions
- Device: LimFlow System
- First Posted Date
- 2019-05-31
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- LimFlow, Inc.
- Target Recruit Count
- 105
- Registration Number
- NCT03970538
- Locations
- ๐บ๐ธ
Boston Medical Center, Boston, Massachusetts, United States
๐บ๐ธPrisma Health -- Midlands, Columbia, South Carolina, United States
๐บ๐ธHarbor-UCLA Medical Center, Torrance, California, United States
PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System
- Conditions
- Critical Limb IschemiaChronic Limb-Threatening Ischemia
- Interventions
- Device: LimFlow System
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2024-05-21
- Lead Sponsor
- LimFlow, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT03124875
- Locations
- ๐บ๐ธ
Medstar Washington Hospital Center, Washington, District of Columbia, United States
๐บ๐ธMetro Health, University of Michigan, Wyoming, Michigan, United States
๐บ๐ธMount Sinai Health System, New York, New York, United States